Literature DB >> 14654661

Relation of prenatal phenylalanine exposure to infant and childhood cognitive outcomes: results from the International Maternal PKU Collaborative Study.

Keith F Widaman1, Colleen Azen.   

Abstract

OBJECTIVE: The primary aims of this study were to model the form of the relation between prenatal exposure to phenylalanine (Phe) and measures of offspring intellectual development and to estimate the developmental relations of maternal demographic, pregnancy-related, and perinatal variables on offspring intelligence during infancy and childhood.
METHODS: The participants were the 413 children and their mothers from the International Maternal PKU Collaborative Study.
RESULTS: Results supported a nonlinear relation between prenatal Phe exposure and offspring cognitive outcomes, with damage to the developing fetus if average Phe levels are above approximately 360 micromol/L. Moreover, prenatal Phe exposure had a strong effect on offspring outcomes at 1 year of age and was the only one of the background, pregnancy-related, or perinatal variables to influence directly offspring outcomes at 2, 4, and 7 years of age.
CONCLUSION: The present study was able to document the importance of prenatal exposure to Phe for predicting offspring cognitive outcomes in the presence of other predictors of these outcomes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654661

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  8 in total

1.  Use of sapropterin dihydrochloride in maternal phenylketonuria. A European experience of eight cases.

Authors:  François Feillet; Ania C Muntau; François-Guillaume Debray; Amelie S Lotz-Havla; Alexandra Puchwein-Schwepcke; Ma'atem Béatrice Fofou-Caillierez; Francjan van Spronsen; Fritz Friedrich Trefz
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

2.  Maternal Phenylketonuria Collaborative Study (MPKUCS)--the 'outliers'.

Authors:  W B Hanley; C Azen; R Koch; K Michals-Matalon; R Matalon; B Rouse; F Trefz; S Waisbren; F de la Cruz
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

3.  Phenylketonuria in Children and Mothers: Genes, Environments, Behavior.

Authors:  Keith F Widaman
Journal:  Curr Dir Psychol Sci       Date:  2009-02-01

4.  Domino liver transplant from a donor with maple syrup urine disease into a recipient with phenylketonuria.

Authors:  Vikram K Raghu; Steven F Dobrowolski; Rakesh Sindhi; Kevin A Strauss; George V Mazariegos; Jerry Vockley; Kyle Soltys
Journal:  Mol Genet Metab Rep       Date:  2022-04-21

5.  A case of maternal PKU syndrome despite intensive patient counseling.

Authors:  Susette Unger; Johannes F W Weigel; Holger Stepan; Christoph G O Baerwald
Journal:  Wien Med Wochenschr       Date:  2009-10

Review 6.  Pulmonary Consequences of Prenatal Inflammatory Exposures: Clinical Perspective and Review of Basic Immunological Mechanisms.

Authors:  Courtney M Jackson; Shibabrata Mukherjee; Adrienne N Wilburn; Chris Cates; Ian P Lewkowich; Hitesh Deshmukh; William J Zacharias; Claire A Chougnet
Journal:  Front Immunol       Date:  2020-06-19       Impact factor: 7.561

7.  Maternal phenylketonuria syndrome: studies in mice suggest a potential approach to a continuing problem.

Authors:  William L Zeile; Helen C McCune; Donald G Musson; Brian O'Donnell; Charles A O'Neill; Laurie S Tsuruda; Roberto T Zori; Philip J Laipis
Journal:  Pediatr Res       Date:  2018-01-31       Impact factor: 3.756

8.  The first study of successful pregnancies in Chinese patients with Phenylketonuria.

Authors:  Lin Wang; Fang Ye; Hui Zou; Kundi Wang; Zhihua Chen; Qin Hui; Bingjuan Han; Chun He; Xiaowen Li; Ming Shen
Journal:  BMC Pregnancy Childbirth       Date:  2020-04-28       Impact factor: 3.007

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.